PHILIP KRUKOW: Open Payments
NPI 1962175109 · TOOELE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 51 payments from 16 companies in 2025. Trend: 2023 $1,372 · 2024 $1,212 · 2025 $909
Food & beverage: $909
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $406 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| Indivior Inc. | 4 | $83 |
| Alkermes, Inc. | 3 | $56 |
| PFIZER INC. | 3 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Seqirus USA Inc | 1 | $25 |
| Tris Pharma Inc | 1 | $22 |
Products named: VRAYLAR, REXULTI, SUBLOCADE, ARISTADA, QULIPTA, NURTEC ODT, CAPLYTA, Flucelvax.
Industry payments across UT — which companies pay providers there.
